WO2019221177A9 - 依存症の予防及び／又は治療薬 - Google Patents

依存症の予防及び／又は治療薬 Download PDF

Info

Publication number
WO2019221177A9
WO2019221177A9 PCT/JP2019/019316 JP2019019316W WO2019221177A9 WO 2019221177 A9 WO2019221177 A9 WO 2019221177A9 JP 2019019316 W JP2019019316 W JP 2019019316W WO 2019221177 A9 WO2019221177 A9 WO 2019221177A9
Authority
WO
WIPO (PCT)
Prior art keywords
prophylactic
dependence
therapeutic drug
present
midbrain
Prior art date
Application number
PCT/JP2019/019316
Other languages
English (en)
French (fr)
Other versions
WO2019221177A1 (ja
Inventor
博喜 濱田
高宏 中山
紀之 内田
Original Assignee
青木 勇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 青木 勇 filed Critical 青木 勇
Priority to JP2020519893A priority Critical patent/JP7231622B2/ja
Publication of WO2019221177A1 publication Critical patent/WO2019221177A1/ja
Publication of WO2019221177A9 publication Critical patent/WO2019221177A9/ja
Priority to JP2023022071A priority patent/JP2023065472A/ja

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

中脳報酬系ドーパミンシステムの異常を発症機序とする依存症の予防及び／又は治療する方法を提供することを目的とし、斯かる課題を解決するために、Ｐ３００阻害剤又はその修飾体を含む組成物を提供する。
PCT/JP2019/019316 2018-05-15 2019-05-15 依存症の予防及び／又は治療薬 WO2019221177A1 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020519893A JP7231622B2 (ja) 2018-05-15 2019-05-15 依存症の予防及び／又は治療薬
JP2023022071A JP2023065472A (ja) 2018-05-15 2023-02-16 依存症の予防及び／又は治療薬

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2018093576 2018-05-15
JP2018093573 2018-05-15
JP2018-093573 2018-05-15
JP2018-093576 2018-05-15

Publications (2)

Publication Number Publication Date
WO2019221177A1 WO2019221177A1 (ja) 2019-11-21
WO2019221177A9 true WO2019221177A9 (ja) 2020-01-09

Family

ID=68539749

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/JP2019/019314 WO2019221176A1 (ja) 2018-05-15 2019-05-15 アルコール依存症又はニコチン依存症の予防及び／又は治療薬
PCT/JP2019/019316 WO2019221177A1 (ja) 2018-05-15 2019-05-15 依存症の予防及び／又は治療薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/JP2019/019314 WO2019221176A1 (ja) 2018-05-15 2019-05-15 アルコール依存症又はニコチン依存症の予防及び／又は治療薬

Country Status (3)

Country Link
JP (2) JP7231622B2 (ja)
CN (1) CN113423407A (ja)
WO (2) WO2019221176A1 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111961560B (zh) * 2020-07-22 2023-04-28 浙江中医药大学 一种姜菊露酒及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003073329A (ja) * 2001-09-04 2003-03-12 Kagome Co Ltd アルデヒドデヒドロゲナーゼ阻害剤
JP2005312325A (ja) * 2004-04-27 2005-11-10 Sanei Gen Ffi Inc 新規糖転移酵素、及びそれを利用したクルクミン配糖体の製造
CN102764408B (zh) * 2012-01-18 2014-07-16 上海蓝怡科技有限公司 一种解酒制剂
CA2878402A1 (en) * 2012-07-06 2014-01-09 Omeros Corporation Andrographis paniculata compositions and methods for treatment of addictions

Also Published As

Publication number Publication date
JP7231622B2 (ja) 2023-03-01
JPWO2019221177A1 (ja) 2021-06-10
CN113423407A (zh) 2021-09-21
JP2023065472A (ja) 2023-05-12
WO2019221177A1 (ja) 2019-11-21
WO2019221176A1 (ja) 2019-11-21

Similar Documents

Publication Publication Date Title
SG10201908697XA (en) A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease
MX2020007625A (es) Inhibidor mtor, composicion farmaceutica y su uso.
MX2018013387A (es) Inhibidores de la arginasa y sus aplicaciones terapeuticas.
PH12019502646A1 (en) Pyrazole magl inhibitors
MX2021001807A (es) Combinacion de un inhibidor de histona desacetilasa y un inhibidor de proteina cinasa y uso farmaceutico de la misma.
PH12020551934A1 (en) Magl inhibitors
BR112021017350A2 (pt) Combinação de conjugado de anticorpo-derivado de pirrolobenzodiazepina e inibidor de parp
BR112021019262A2 (pt) Uso de ciclo-his-pro (chp) para prevenir, atenuar ou tratar fibrose
BR112016001781A2 (pt) inibidores de rorc2 e métodos de uso dos mesmos
PH12019502548A1 (en) Pyrazole magl inhibitors
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
WO2018208793A8 (en) S-NITROSOGLUTATHIOME INHIBITORS (GSNO) AND GSNO REDUCTASE USEFUL IN THERAPY
MY201921A (en) Agent for preventing or treating fat-associated diseases and/or inflammation
CR20220216A (es) Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1
EP4223306A3 (en) Treatment of ciliopathies
WO2017098051A3 (en) Combined preparations of pkm2 modulators and hmgb1
CA3035115C (en) Nitrogenous heterocyclic aromatic compound, preparation method therefor, pharmaceutical composition thereof, and application thereof
CR20210507A (es) Composición farmacéutica acuosa de anticuerpo anti-il17a y su uso
MX2021004709A (es) Metodo y medicamento para tratar cancer insensible a inhibidor de se?alizacion de pd-1/pd-l1.
WO2019221177A9 (ja) 依存症の予防及び／又は治療薬
AU2017258649A1 (en) Covalent BTK inhibitors and uses thereof
MX2022005388A (es) Compuestos de pirrolidina y piperidina.
WO2020109233A3 (en) Trmt2a inhibitors for use in the treatment of polyglutamine diseases
AU2018258588A8 (en) Inhibitors of TRIM33 and methods of use
WO2019155360A3 (en) Pharmaceutical composition for treating bacterial and viral infections

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19803439

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2020519893

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19803439

Country of ref document: EP

Kind code of ref document: A1